Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Sta 4783
2. Sta-4783
3. Sta4783
1. 488832-69-5
2. Sta-4783
3. Elesclomol (sta-4783)
4. N'1,n'3-dimethyl-n'1,n'3-di(phenylcarbonothioyl)malonohydrazide
5. Elesclomol [usan]
6. Chebi:79369
7. Propanedioic Acid, Bis[2-methyl-2-(phenylthioxomethyl)hydrazide]
8. 6uk191m53p
9. Gsk-842879a
10. Elesclomol (usan)
11. Gsk-842879
12. 1,3-bis[2-methyl-2-(phenylthioxomethyl)hydrazide]propanedioic Acid
13. 1-n',3-n'-bis(benzenecarbonothioyl)-1-n',3-n'-dimethylpropanedihydrazide
14. 1-n'-benzenecarbothioyl-3-(2-benzenecarbothioyl-2-methylhydrazinyl)-n'-methyl-oxopropanehydrazidide
15. Elesclomol [usan:inn]
16. Elesclomolum
17. Unii-6uk191m53p
18. N'1,n'3-dimethyl-n'1,n'3-bis(phenylcarbonothioyl)propanedihydrazide
19. Propanedioic Acid, Bis(2-methyl-2-(phenylthioxomethyl)hydrazide)
20. Sta4783
21. Sta 4783
22. Nsc174939
23. Elesclomol [mi]
24. Elesclomol [inn]
25. Elesclomol [mart.]
26. Elesclomol [who-dd]
27. Mls006011164
28. Schembl313745
29. Chembl1972860
30. Dtxsid2042642
31. Schembl10131773
32. Ex-a602
33. Hms3654m11
34. Hms3868i03
35. Bcp00247
36. Zinc1716098
37. Mfcd12911784
38. S1052
39. Akos005145783
40. Bcp9000639
41. Ccg-264795
42. Cs-0192
43. Db05719
44. Nsc-174939
45. Sb17208
46. Ncgc00183656-01
47. Ncgc00183656-02
48. Ncgc00183656-09
49. Ncgc00183656-11
50. Ac-35840
51. As-56232
52. Hy-12040
53. Nci60_001429
54. Smr004702933
55. Ft-0700480
56. Sw219775-1
57. Ec-000.2312
58. A23836
59. D08909
60. H11160
61. 832e695
62. J-503879
63. N-malonyl-bis (n'-methyl-n'-thiobenzoyl Hydrazide)
64. Q5359460
65. Brd-k82135108-001-01-9
66. N,n'-bis[methyl[phenyl(thiocarbonyl)]amino]malonamide
67. N'(1),n'(3)-dimethyl-n'(1),n'(3)-bis(phenylcarbonothioyl)malonohydrazide
68. 1-n'-benzenecarbothioyl-3-(2-benzene Carbothioyl-2-methylhydrazinyl)-n'-methyloxopropanehydrazidide
Molecular Weight | 400.5 g/mol |
---|---|
Molecular Formula | C19H20N4O2S2 |
XLogP3 | 2.9 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 4 |
Exact Mass | 400.10276824 g/mol |
Monoisotopic Mass | 400.10276824 g/mol |
Topological Polar Surface Area | 129 Ų |
Heavy Atom Count | 27 |
Formal Charge | 0 |
Complexity | 510 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Investigated for use/treatment in melanoma.
Elesclomol is a first-in-class heat shock protein 70 (Hsp70) inducer that activates natural killer (NK) cell-mediated tumor killing.
Elesclomol acts through a novel mechanism of action. Elesclomol has been shown to rapidly cause a dramatic increase in oxidative stress (ROS) inside cancer cells. The prolonged elevation of ROS inside cancer cells induced by elesclomol causes the cell to exceed a critical breaking point and undergo apoptosis. The triggering of the mitochondrial apoptosis pathway is observed within the first six hours of applying elesclomol. Cancer cells operate at a much higher intrinsic level of ROS than normal cells, and have a greatly reduced anti-oxidant capacity compared to normal cells. This leaves them more vulnerable to an agent such as elesclomol that elevates oxidative stress. In similar experiments at similar doses, elesclomol has been found to have little to no impact on normal cells.
ABOUT THIS PAGE
A Elesclomol manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Elesclomol, including repackagers and relabelers. The FDA regulates Elesclomol manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Elesclomol API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Elesclomol manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Elesclomol supplier is an individual or a company that provides Elesclomol active pharmaceutical ingredient (API) or Elesclomol finished formulations upon request. The Elesclomol suppliers may include Elesclomol API manufacturers, exporters, distributors and traders.
click here to find a list of Elesclomol suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Elesclomol Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Elesclomol GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Elesclomol GMP manufacturer or Elesclomol GMP API supplier for your needs.
A Elesclomol CoA (Certificate of Analysis) is a formal document that attests to Elesclomol's compliance with Elesclomol specifications and serves as a tool for batch-level quality control.
Elesclomol CoA mostly includes findings from lab analyses of a specific batch. For each Elesclomol CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Elesclomol may be tested according to a variety of international standards, such as European Pharmacopoeia (Elesclomol EP), Elesclomol JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Elesclomol USP).
LOOKING FOR A SUPPLIER?